Efficacy and safety of endoscopic prophylactic treatment with undiluted cyanoacrylate for gastric varices

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

515

HTML

3325

Figures (1-1)

234

Tables (1-3)

204

Sum=4278

Publishing Process of This Article

Item

Count

Browse

1070

Download

1190

Sum=2260

Jun 16, 2014 (publication date) through Dec 20, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastrointest Endosc. Jun 16, 2014; 6(6): 254-259
Published online Jun 16, 2014. doi: 10.4253/wjge.v6.i6.254

Table 3 Overall results of gastric varices treatment with cyanoacrylate injection n (%)

Characteristics	Patients (n = 20)
GV eradication	20 (100)
Number of sessions
1	13 (65)
2	7 (35)
Mean volume NBCM injected in mL	1.37 ± 0.48
Recurrence rate
3 mo	0
6 mo	1 (5)
> 2 yr	1 (5)
Total	2 (10)
Median follow-up in months (range)	31 (6-40)
Late bleeding rate	1 (5)
Minor adverse events¹	3 (15)
Major adverse events	0
Overall mortality rate	0

¹Epigastric pain. GV: Gastric varices; NBCM: N-butyl-2 cyanoacrylate plus methacryloxysulfolane.

Citation: Franco MC, Gomes GF, Nakao FS, de Paulo GA, Ferrari Jr AP, Libera Jr ED. Efficacy and safety of endoscopic prophylactic treatment with undiluted cyanoacrylate for gastric varices. World J Gastrointest Endosc 2014; 6(6): 254-259
URL: https://www.wjgnet.com/1948-5190/full/v6/i6/254.htm
DOI: https://dx.doi.org/10.4253/wjge.v6.i6.254